{
    "organizations": [],
    "uuid": "df9b02d676c366b7b90d47dad3b477adcdfc9a33",
    "author": "",
    "url": "https://www.reuters.com/article/brief-united-therapeutics-settles-patent/brief-united-therapeutics-settles-patent-litigation-with-actavis-laboratories-fl-idUSFWN1Q51JZ",
    "ord_in_thread": 0,
    "title": "BRIEF-United Therapeutics Settles Patent Litigation With Actavis Laboratories FL",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - United Therapeutics Corp:\n* UNITED THERAPEUTICS ANNOUNCES SETTLEMENT OF PATENT LITIGATION WITH ACTAVIS LABORATORIES FL, INC. RELATING TO ORENITRAM\n* ‍ENTERED INTO A SETTLEMENT AGREEMENT WITH ACTAVIS LABORATORIES FL, INC RESOLVING ONGOING LITIGATION​\n* ‍UNDER SETTLEMENT AGREEMENT, CO GRANTED TO ACTAVIS LICENSE TO MANUFACTURE AND COMMERCIALIZE GENERIC VERSION OF ORENITRAM\n* SAYS PARTIES WILL ALSO TERMINATE PENDING LITIGATION CONCERNING PATENTS RELATING TO ACTAVIS’ ANDA.\n* UNITED THERAPEUTICS - ‍LICENSE IN SETTLEMENT AGREEMENT DOES NOT PERMIT ACTAVIS TO MANUFACTURE GENERIC VERSION OF ANY OTHER UNITED THERAPEUTICS PRODUCT​\n* ‍ AGREEMENT DOES NOT GRANT ACTAVIS ANY RIGHTS OTHER THAN THOSE REQUIRED TO LAUNCH ACTAVIS’ GENERIC VERSION OF ORENITRAM​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-16T03:08:00.000+02:00",
    "crawled": "2018-02-16T03:30:31.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "united",
        "therapeutic",
        "corp",
        "united",
        "therapeutic",
        "announces",
        "settlement",
        "patent",
        "litigation",
        "actavis",
        "laboratory",
        "fl",
        "relating",
        "orenitram",
        "settlement",
        "agreement",
        "actavis",
        "laboratory",
        "fl",
        "inc",
        "resolving",
        "ongoing",
        "settlement",
        "agreement",
        "co",
        "granted",
        "actavis",
        "license",
        "manufacture",
        "commercialize",
        "generic",
        "version",
        "orenitram",
        "say",
        "party",
        "also",
        "terminate",
        "pending",
        "litigation",
        "concerning",
        "patent",
        "relating",
        "actavis",
        "anda",
        "united",
        "therapeutic",
        "settlement",
        "agreement",
        "permit",
        "actavis",
        "manufacture",
        "generic",
        "version",
        "united",
        "therapeutic",
        "agreement",
        "grant",
        "actavis",
        "right",
        "required",
        "launch",
        "actavis",
        "generic",
        "version",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}